World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000027918
Date of registration: 25/06/2017
Prospective Registration: No
Primary sponsor: Department of Urology and Renal transplantation, Nagasaki University Hospital
Public title: Heparin-lidocaine intravesical injection therapy for refractory interstitial cystitis
Scientific title: Heparin-lidocaine intravesical injection therapy for refractory interstitial cystitis - Heparin-lidocaine intravesical injection therapy for interstitial cystitis
Date of first enrolment: 2016/07/01
Target sample size: 30
Recruitment status: Recruiting
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031980
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:     Tomohiro Matsuo
Address:  1-7-1 Sakamoto, Nagasaki city, Nagasaki, Japan Japan
Telephone: 095-819-7340
Email: tomo1228@nagasaki-u.ac.jp
Affiliation:  Nagasaki University Hospital Department of Urology and Renal transplantation
Name:     Yasuyoshi Miyata
Address:  1-7-1 Sakamoto, Nagasaki city, Nagasaki, Japan Japan
Telephone: 095-819-7340
Email: int.doc.miya@m3.dion.ne.jp
Affiliation:  Nagasaki University Hospital Department of Urology and Renal transplantation
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: 1. Patients with active urinary tract infection, urinary tract hemorrhage, urinary tract malignancy 2. Patients with systolic blood pressure of 200 mmHg or more or less than 89 mmHg and diastolic blood pressure of 80 mmHg or more 3. Patients with serious liver and kidney dysfunction 4. Patients with drug hypersensitivity such as allergies 5. Pregnant women and patients who may be pregnant or breast-feeding patients 6. Patients who participated in other clinical studies within 4 months 7. Patients whose research managers judged inappropriate as research subjects

Age minimum: 20years-old
Age maximum: 80years-old
Gender: Male and Female
Health Condition(s) or Problem(s) studied
interstitial cystitis
Intervention(s)
heparin-lidocaine intravesical therapy
Primary Outcome(s)
urinary frequency
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Department of Urology and Renal transplantation, Nagasaki University Hospital
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history